A randomized controlled trial of N-acetylcysteine in the treatment of early-onset preeclampsia: Study Protocol
Kehinde S Okunade, Adebola A Adejimi, Muisi A Adenekan, Iyabo Y Ademuyiwa, Hameed Adelabu, Fatimah M Habeebu-Adeyemi, Adaiah P Soibi-Harry, Ololade Onasanya · 2026
Read A randomized controlled trial of N-acetylcysteine in the treatment of early-onset preeclampsia: Study Protocol by Kehinde S Okunade, Adebola A Adejimi, Muisi A Adenekan, Iyabo Y Ademuyiwa, Hameed Adelabu, Fatimah M Habeebu-Adeyemi, Adaiah P Soibi-Harry, Ololade Onasanya (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/plos-pone-0347695.txt.
Description
Preeclampsia, a dangerous blood pressure disorder of pregnancy, can worsen fast, and few treatments slow it. Kehinde S Okunade and colleagues present a trial plan, in PLOS One in 2026, testing whether a common antioxidant drug can delay that worsening in Lagos, Nigeria.
About one hundred fifty women diagnosed early, between roughly six and eight months of pregnancy, will take a daily tablet of the drug or a look-alike placebo alongside normal care. Neither patients nor staff will know who gets which. The main measure is how many days pass before the disease advances. Results are not yet available; the trial runs through 2028.
Catalog record
| CREATOR | Kehinde S Okunade, Adebola A Adejimi, Muisi A Adenekan, Iyabo Y Ademuyiwa, Hameed Adelabu, Fatimah M Habeebu-Adeyemi, Adaiah P Soibi-Harry, Ololade Onasanya |
|---|---|
| YEAR | 2026 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 34483 |
| LICENSE | CC_BY |
| RIGHTS | CC BY |
| SOURCE | PLOS |